Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

BioMarin

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of BioMarin's 2012 metabolic sales performance.

NICE knocks back BioMarin’s Batten disease drug

NICE knocks back BioMarin’s Batten disease drug England’s cost-effectiveness watchdog has today rejected BioMarin’s Battten disease therapy Brineura (cerliponase alfa) during final guidance. ... The decision, which was published under NICE’s Highly Specialised Technology (HST) committee, marks

BioMarin prepares for haemophilia A gene therapy data readout, filing

BioMarin prepares for haemophilia A gene therapy data readout, filing The company has rivals close behind it – Spark and Pfizer and Sangamo, but BioMarin could gain the upper hand this year if its data is robust. ... to $1bn.  The product was launched in the US last year and BioMarin expect a recommendation from

European biosimilars hit AbbVie’s Humira revenues in Q4

European biosimilars hit AbbVie’s Humira revenues in Q4 disease specialists BioMarin and Alexion.

Astellas, Catalyst approvals set up record year for FDA approvals

Astellas, Catalyst approvals set up record year for FDA approvals The drug was originally developed by BioMarin, which got EU approval in 2009 and licensed it to Catalyst three years later.

BioMarin eyes 2019 FDA filing for haemophilia A gene therapy

BioMarin eyes 2019 FDA filing for haemophilia A gene therapy Valrox phase 1/2 data conforms to regulatory requirements for expedited registration,” said Geoff Nichol, BioMarin’s chief medical officer, during the update. ... our development and accelerated regulatory strategy,” said BioMarin’s chief

[ Previous 5 results ] 3 4 5 6 7 8 9 10 11 12 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
OUTiCO

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

The search for treatments for Parkinson’s disease
The research requires resilience but pharma is urged to ‘keep innovating, keep trying’...
Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
Ditch the Label – it’s just me....
The impact of COVID-19 on clinical trials
As all industry sectors work to assess both the impact and the optimal path forward, the effects are expected to be diverse and long-lasting...

Infographics